Company news
Aligos Therapeutics, Inc. news in 2025
Aligos Therapeutics, Inc.'s news releases, calls and decks from 2025, newest first.
Aligos Therapeutics Presents Positive Data at HEP-DART 2025
December 11, 2025
Aligos Therapeutics Presents Positive Data at The Liver Meeting® 2025
November 10, 2025
Aligos Therapeutics Reports Recent Business Progress and Third Quarter 2025 Financial Results
November 6, 2025
Aligos Therapeutics to Present at Upcoming Investor Conferences
November 4, 2025
Aligos Therapeutics to Announce 3rd Quarter 2025 Financial Results on November 6, 2025
October 30, 2025
Aligos Therapeutics Receives USAN Council Approval for pevifoscorvir sodium as Nonproprietary Name for ALG-000184
October 16, 2025
Aligos Therapeutics to Present at the H.C. Wainwright Liver Disease Conference
October 14, 2025
Aligos Therapeutics Announces Eight Abstracts Accepted at The Liver Meeting® 2025
October 7, 2025
Aligos Therapeutics Announces Six Preclinical Presentations at the 2025 International HBV Meeting
September 3, 2025
Aligos Therapeutics to Present at the H.C. Wainwright 27th Annual Global Investment Conference
September 2, 2025
Aligos Therapeutics Strengthens Senior Leadership Team with the Appointment of Ramón Polo as Senior Vice President, Head of Global Regulatory Affairs
August 20, 2025
Aligos Therapeutics Announces First Subject Dosed in the Phase 2 B-SUPREME Study of ALG-000184 in Subjects with Chronic HBV Infection
August 13, 2025
Aligos Therapeutics Reports Recent Business Progress and Second Quarter 2025 Financial Results
August 6, 2025
Aligos Therapeutics to Announce 2nd Quarter 2025 Financial Results on August 6, 2025
July 30, 2025
Aligos Therapeutics Appoints Kieron Wesson as Vice President, Head of Chemistry Manufacturing Controls (CMC)
June 18, 2025
Aligos Therapeutics to Present at the Jefferies Global Healthcare Conference
May 29, 2025
Aligos Therapeutics Appoints Laura Kavanaugh as Vice President, Head of Legal
May 20, 2025
Aligos Therapeutics Presents Positive Data at the EASL Congress 2025
May 8, 2025
Aligos Therapeutics Reports Recent Business Progress and First Quarter 2025 Financial Results
May 6, 2025
Aligos Therapeutics to Announce 1st Quarter 2025 Financial Results on May 6, 2025
April 29, 2025
Aligos Therapeutics Announces Eight Abstracts Accepted for Presentation at the EASL Congress 2025
April 23, 2025
Aligos Therapeutics Presents Positive Data at APASL 2025
March 26, 2025
Aligos Therapeutics Reports Recent Business Progress and Fourth Quarter and Full Year 2024 Financial Results
March 10, 2025
Aligos Therapeutics to Announce 4th Quarter 2024 Financial Results on March 10, 2025
March 3, 2025
Aligos Therapeutics Announces $105 Million Private Placement Financing
February 11, 2025
Decks in 2025
- APASL 2025
Conference · 19 slides · March 2025